Information Journal Paper
APA:
Copy. (2017). SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis. PLOS ONE, 12(9), 0-0. SID. https://sid.ir/paper/671155/en
Vancouver:
Copy. SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis. PLOS ONE[Internet]. 2017;12(9):0-0. Available from: https://sid.ir/paper/671155/en
IEEE:
Copy, “SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis,” PLOS ONE, vol. 12, no. 9, pp. 0–0, 2017, [Online]. Available: https://sid.ir/paper/671155/en